[go: up one dir, main page]

PE20030207A1 - Soluciones de acido acetilsalicilico - Google Patents

Soluciones de acido acetilsalicilico

Info

Publication number
PE20030207A1
PE20030207A1 PE2001000218A PE2001000218A PE20030207A1 PE 20030207 A1 PE20030207 A1 PE 20030207A1 PE 2001000218 A PE2001000218 A PE 2001000218A PE 2001000218 A PE2001000218 A PE 2001000218A PE 20030207 A1 PE20030207 A1 PE 20030207A1
Authority
PE
Peru
Prior art keywords
volume
acid solutions
solvent
solution
water
Prior art date
Application number
PE2001000218A
Other languages
English (en)
Inventor
Wolfgang Wiehl
Martina Wirtz
Dietmar Bahn
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PE20030207A1 publication Critical patent/PE20030207A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE REFIERE A SOLUCIONES DE 3g A 30 g DE ACIDO ACETILSALICILO, CONTENIENDO EL DISOLVENTE DE 1 A 20% EN VOLUMEN DE AGUA Y 80 A 99% EN VOLUMEN DE DISOLVENTE ORGANICO EN 100 ml DE SOLUCION. EL DISOLVENTE ORGANICO SE SELECCIONA DE ETANOL, PROPANO, ISOPROPANOL, BUTANO, ISOBUTANOL, ENTRE OTROS. EL DISOLVENTE COENTINE DE 30% A 80% DE VOLUMEN DE ETER , DE 17% A 67% DE VOLUMEN DE ALCOHOL O ACETONA Y DE 3% A 10% EN VOLUMEN DE AGUA. LA SOLUCION ES UTIL PARA EL TRATAMIENTO TOPICO DEL DOLOR COMO HERPES ZOSTER, PRURITO, NEURODERMITIS
PE2001000218A 2000-03-07 2001-03-06 Soluciones de acido acetilsalicilico PE20030207A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10011032A DE10011032A1 (de) 2000-03-07 2000-03-07 Acetylsalicylsäure-Lösungen

Publications (1)

Publication Number Publication Date
PE20030207A1 true PE20030207A1 (es) 2003-04-16

Family

ID=7633806

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000218A PE20030207A1 (es) 2000-03-07 2001-03-06 Soluciones de acido acetilsalicilico

Country Status (9)

Country Link
EP (1) EP1263441A2 (es)
AR (1) AR028237A1 (es)
AU (1) AU2001272099A1 (es)
DE (1) DE10011032A1 (es)
GT (1) GT200100035A (es)
HN (1) HN2001000039A (es)
PE (1) PE20030207A1 (es)
SV (1) SV2002000339A (es)
WO (1) WO2001066115A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1716855A4 (en) * 2004-02-16 2008-06-18 Teikoku Seiyaku Kk REMEDY FOR EXTERNAL USE FOR SKIN AND MUCOUS DISEASES CAUSED BY VIRAL INFECTION
US8114910B2 (en) 2006-05-02 2012-02-14 Pfeinsmith S.A. (Pty) Ltd. Acidic composition
CA3064012A1 (en) * 2017-05-30 2018-12-06 Rhoshan Pharmaceuticals, Inc. In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219548A (en) * 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives
SK96196A3 (en) * 1994-01-24 1997-03-05 Procter & Gamble Process for solubilizing difficultly soluble pharmaceutical actives

Also Published As

Publication number Publication date
HN2001000039A (es) 2001-07-09
SV2002000339A (es) 2002-06-07
DE10011032A1 (de) 2001-09-13
EP1263441A2 (de) 2002-12-11
AR028237A1 (es) 2003-04-30
GT200100035A (es) 2001-12-18
WO2001066115A3 (de) 2002-02-14
WO2001066115A2 (de) 2001-09-13
AU2001272099A1 (en) 2001-09-17

Similar Documents

Publication Publication Date Title
PE49296A1 (es) Procedimiento para preparar clorhidrato de 1-(2`-desoxi-2',2'-difluoro-d-ribofuranosil)-4-aminopirimidin-2-ona
MD1587C2 (ro) Eteri de 2,6-dihidroxipiridină, procedeu de preparare a lor, compoziţie erbicidă şi metodă de combatere a creşterii plantelor indezirabile
ES2052518T3 (es) Agente viricida con efecto de amplio espectro.
PE20050945A1 (es) Ester de rapamicin-42 amorfo con el acido 3-hidroxi-2-(hidroximetil)-2-metilpropionico y sus composiciones farmaceuticas
BRPI0307117B8 (pt) amidas de ácido antranílico e seus derivados, bem como seus usos como compostos ativos cosméticos e farmacêuticos
ATE55906T1 (de) Dermatologische fungizide loesung.
AU1018992A (en) Cosmetic composition
ES2125535T5 (es) Mezclas, que contienen isocianatos emulsionables en agua.
PE20030207A1 (es) Soluciones de acido acetilsalicilico
FR2461499A1 (fr) Composition pharmaceutique a base d'extraits de myrtille
ES2143443T3 (es) Espesantes polimeros para composiciones acuosas.
ES2197632T3 (es) Procedimiento de preparacion de aloina por extraccion.
ATE376427T1 (de) Pharmazeutische zusammensetzungen aus bartflechten (usnea barbata) und johanniskraut (hypericum perforatum) sowie ihre verwendung
Dubasi et al. Applications of Alum (KAl (SO4) 2.12 H2O) in organic synthesis and as catalysis: a quinquennial update (2017-2022)
PE18195A1 (es) Proceso para preparar un derivado piperidinico de indol
Panichayupakaranant et al. Evaluation of chemical stability and skin irritation of lawsone methyl ether in oral base
AR010178A1 (es) Preparados farmaceuticos que contienen como principio activo cilansetron, empleo de aditivos y procedimiento para la produccion de dichos preparados
CA2067807A1 (en) Alcoholic aqueous gel-type phospholipid composition, its use and topical preparations containing it
ES2078054T3 (es) Curtientes diluibles de triformiato de aluminio en forma altamente concentrada soluble en agua y estable al almacenamiento y su empleo.
BR9807056A (pt) Uso de álcool diclorobenzìlico, e preparação para tratamento tópico da inflamação
ES8705463A1 (es) Un procedimiento para la preparacion de 1-metil-4,5-dihi- droorotil-histidil-prolinamida
Avi-Dor et al. The effect of antibiotics on the photocycle and protoncycle of purple membrane suspensions
JPS5655307A (en) Opacifying cosmetic
Ali et al. Screening for the antimicrobial properties of the leaves of Calophyllum inophyllum Linn.(Guttiferae)
Peters et al. The Synthesis of Some 2, 4, 5-Trisubstituted Pyrimidines1

Legal Events

Date Code Title Description
FA Abandonment or withdrawal